IP Verse

Treating Fibrosis And Inflammation By Inhibiting Tl1A - EP2978440B1

PatentPatent Analysis

EP2978440

CEDARS SINAI MEDICAL CENTER
Application Number
EP14773989A
Filing Date
Mar 27, 2014
Status
Revoked
Jul 29, 2022
Grant Date
Oct 2, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3458466B1
EP3639841B1

Bibliography

The patent EP2978440B1 was granted to Cedars Sinai Medical Center on Oct 2, 2019 following the initial filing on Mar 27, 2014 under the application number EP14773989A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJul 1, 2020 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents